Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah's Q3 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah’s Q3 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation. Our first innovation is Genio®, a battery-free hypoglossal neuromodulation device that is inserted through a single incision under the chin and controlled by a wearable. Through our commitment to innovation and clinical evidence, we have shown best-in-class outcomes for reducing OSA burden.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD-LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' or managements' current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and reporting data from Nyxoah’s DREAM U.S. pivotal trial; receipt of FDA approval; entrance to the U.S. market; and the anticipated closing and use of the proceeds from the offering. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the offering, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

Contacts:

Nyxoah
Loïc Moreau, Chief Financial Officer
IR@nyxoah.com

For Media
In United States
FINN Partners – Glenn Silver
glenn.silver@finnpartners.com

In Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

In International/Germany
MC Services – Anne Hennecke
nyxoah@mc-services.eu

Attachment

  • ENGLISH_Q3 2024 Earnings Call Save-the-Date


Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

THỦ THUẬT HAY

Cách làm đèn flash nháy sáng khi có cuộc gọi, tin nhắn, hay thông báo

Đèn flash nháy sáng ngoài tác dụng trợ sáng khi chụp hình còn có thể là đèn báo khi có điện thoại ​ hay tin nhắn giúp bạn không bỏ lỡ bất kì thông báo nào.

Hướng dẫn bạn cách xóa gợi ý tìm kiếm trên Messenger cực dễ

Trong bài này, sẽ hướng dẫn các bạn cách xóa gợi ý tìm kiếm trên Messenger. Qua đó giúp bạn xóa những người lạ trong danh sách online trên Messenger chỉ với vài thao tác đơn giản.

Hướng dẫn điều chỉnh độ nhạy nút Home trên các thiết bị IOS

Khi sử dụng các thiết bị chạy hệ điều hành iOS của Apple như iPhone, iPad, người dùng đôi lúc sẽ gặp phải khó khăn do nút home trên thiết bị của họ quá nhạy.

Cách chia sẻ máy in giữa Windows, Mac và Linux trong cùng một mạng

Giả sử bạn có một hệ thống bao gồm đầy đủ các hệ điều hành như Windows, Mac và Linux, vậy làm thế nào để bạn có thể chia sẻ máy in giữa Windows, Mac và Linux giữa chúng trong cùng một mạng. Bài viết dưới đây sẽ mật bí

Giải mã cách thức hoạt động mạng xã hội mua sắm Spark của Amazon

Amzon luôn muốn bạn mua sắm nhiều hơn và vì lý do đó Amazon đã ra mắt Spark - mạng xã hội mua sắm theo phong cách Instagram, xuất hiện bên trong các ứng dụng Amazon để trưng bày sản phẩm. Hãy cùng khám phá cách thức

ĐÁNH GIÁ NHANH

Đánh giá Lenovo Yoga 920: Sở hữu hàng loạt nâng cấp mới

Thừa hưởng từ Yoga 910, Lenovo Yoga 920 tiếp tục sở hữu thiết kế 2 trong 1 với phần bản lề dạng dây đồng hồ rất đẹp mắt. Sản phẩm được hoàn thiện từ khung nhôm chắc chắn, viền màn hình được làm rất mỏng nhưng cụm

Trên tay Galaxy Note8 Orchid Grey: Màu sắc mới mẻ và lạ mắt, giá 22.49 triệu đồng

Tím khói, Orchid Grey hay còn được gọi vui với cái tên “màu mắm tôm” là một màu sắc cực kỳ đặc biệt, từng được Samsung áp dụng trên mẫu sản phẩm Galaxy S8/S8 Plus và nhận được rất nhiều phản hồi tích cực từ phía người